You can:
Name | Galanin receptor type 1 |
---|---|
Species | Rattus norvegicus (Rat) |
Gene | Galr1 |
Synonym | GAL1 receptor GAL1-R GALNR GALNR1 GALR-1 |
Disease | N/A for non-human GPCRs |
Length | 346 |
Amino acid sequence | MELAPVNLSEGNGSDPEPPAEPRPLFGIGVENFITLVVFGLIFAMGVLGNSLVITVLARSKPGKPRSTTNLFILNLSIADLAYLLFCIPFQATVYALPTWVLGAFICKFIHYFFTVSMLVSIFTLAAMSVDRYVAIVHSRRSSSLRVSRNALLGVGFIWALSIAMASPVAYYQRLFHRDSNQTFCWEHWPNQLHKKAYVVCTFVFGYLLPLLLICFCYAKVLNHLHKKLKNMSKKSEASKKKTAQTVLVVVVVFGISWLPHHVIHLWAEFGAFPLTPASFFFRITAHCLAYSNSSVNPIIYAFLSENFRKAYKQVFKCRVCNESPHGDAKEKNRIDTPPSTNCTHV |
UniProt | Q62805 |
Protein Data Bank | N/A |
GPCR-HGmod model | N/A |
3D structure model | No available structures or models |
BioLiP | N/A |
Therapeutic Target Database | N/A |
ChEMBL | CHEMBL5504 |
IUPHAR | N/A |
DrugBank | N/A |
Name | M-40 |
---|---|
Molecular formula | C94H145N23O24 |
IUPAC name | (2S)-2-[[(2S)-2-[[(2S,3R)-2-[[(2S)-2-[(2-amino-1-hydroxyethylidene)amino]-1-hydroxy-3-(1H-indol-3-yl)propylidene]amino]-1,3-dihydroxybutylidene]amino]-1-hydroxy-4-methylpentylidene]amino]-N-[(2S)-1,3-dihydroxy-1-[(2S)-1-hydroxy-1-[2-hydroxy-2-[(2S)-1-hydroxy-1-[(2S)-1-hydroxy-1-[(2S)-1-hydroxy-1-[2-[(2S)-2-[(2S)-2-[(2S)-2-[C-hydroxy-N-[(2S)-1-hydroxy-1-[(2S)-1-hydroxy-1-[(2S)-1-hydroxy-1-[(2S)-1-hydroxy-1-[(2S)-1-hydroxy-1-iminopropan-2-yl]imino-4-methylpentan-2-yl]iminopropan-2-yl]imino-4-methylpentan-2-yl]iminopropan-2-yl]carbonimidoyl]pyrrolidine-1-carbonyl]pyrrolidine-1-carbonyl]pyrrolidin-1-yl]-2-oxoethyl]imino-4-methylpentan-2-yl]imino-4-methylpentan-2-yl]imino-3-(4-hydroxyphenyl)propan-2-yl]iminoethyl]iminopropan-2-yl]iminopropan-2-yl]butanediimidic acid |
Molecular weight | 1981.33 |
Hydrogen bond acceptor | 43 |
Hydrogen bond donor | 25 |
XlogP | 9.8 |
Synonyms | N/A |
Inchi Key | OSGCBUDLRBUEGW-JZCUZNMGSA-N |
Inchi ID | InChI=1S/C94H145N23O24/c1-46(2)33-61(82(129)100-44-76(124)115-30-19-24-71(115)93(140)117-32-20-25-72(117)94(141)116-31-18-23-70(116)91(138)104-54(14)81(128)108-63(35-48(5)6)84(131)103-53(13)80(127)107-62(34-47(3)4)83(130)101-51(11)78(97)125)109-85(132)64(36-49(7)8)110-87(134)66(38-56-26-28-58(120)29-27-56)106-75(123)43-99-79(126)52(12)102-90(137)69(45-118)113-88(135)68(40-73(96)121)111-86(133)65(37-50(9)10)112-92(139)77(55(15)119)114-89(136)67(105-74(122)41-95)39-57-42-98-60-22-17-16-21-59(57)60/h16-17,21-22,26-29,42,46-55,61-72,77,98,118-120H,18-20,23-25,30-41,43-45,95H2,1-15H3,(H2,96,121)(H2,97,125)(H,99,126)(H,100,129)(H,101,130)(H,102,137)(H,103,131)(H,104,138)(H,105,122)(H,106,123)(H,107,127)(H,108,128)(H,109,132)(H,110,134)(H,111,133)(H,112,139)(H,113,135)(H,114,136)/t51-,52-,53-,54-,55+,61-,62-,63-,64-,65-,66-,67-,68-,69-,70-,71-,72-,77-/m0/s1 |
PubChem CID | 101218346 |
ChEMBL | CHEMBL604990 |
IUPHAR | N/A |
BindingDB | 50307254 |
DrugBank | N/A |
Structure | |
Lipinski's druglikeness | This ligand has more than 5 hydrogen bond donor. This ligand has more than 10 hydrogen bond acceptor. This ligand is heavier than 500 daltons. This ligand has a partition coefficient log P greater than 5. |
Parameter | Value | Reference | Database source |
---|---|---|---|
Ki | 0.9 nM | PMID9108306 | BindingDB |
Ki | 4.0 nM | PMID9305929 | BindingDB |
Ki | 6.76 nM | PMID9722565 | BindingDB |
zhanglabzhanggroup.org | +65-6601-1241 | Computing 1, 13 Computing Drive, Singapore 117417